Skip links

CICON September 28 – October 01, 2022, New York, NY, US & Macrophage-directed Therapies Summit October 4 – 6, 2022, Boston, MA, US

Our CEO Randolf Kerschbaumer will attend the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference (CICON) in New York and the 4th Macrophage-directed Therapies Summit in Boston. Randolf was invited to present at both meetings to share data on the antitumorigenic and TME-modifying potential of our clinical anti-oxMIF antibody ON203. You can download the presented poster here.

Home